We further combined the data of TIMER, cBioPortal, Kaplan–Meier plotter and other databases to analyze the prognostic value of METTL14 and ZC3H13 in breast cancer, their co-expressed genes and related signaling pathways, as well as the relationship between their expression levels and infiltrating immune cells in tumor tissues. This evidence concerns the gene METTL14 and breast cancer.